2-96265261-T-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM1BP4BS2
The NM_017849.4(TMEM127):āc.121A>Gā(p.Ile41Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000781 in 1,587,388 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM127 | NM_017849.4 | c.121A>G | p.Ile41Val | missense_variant | Exon 2 of 4 | ENST00000258439.8 | NP_060319.1 | |
TMEM127 | NM_001193304.3 | c.121A>G | p.Ile41Val | missense_variant | Exon 2 of 4 | NP_001180233.1 | ||
TMEM127 | NM_001407283.1 | c.-9+608A>G | intron_variant | Intron 1 of 2 | NP_001394212.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000649 AC: 13AN: 200316Hom.: 0 AF XY: 0.0000633 AC XY: 7AN XY: 110606
GnomAD4 exome AF: 0.0000801 AC: 115AN: 1435170Hom.: 1 Cov.: 31 AF XY: 0.0000730 AC XY: 52AN XY: 712814
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74378
ClinVar
Submissions by phenotype
Pheochromocytoma Uncertain:2
- -
- -
TMEM127-related disorder Uncertain:1
The TMEM127 c.121A>G variant is predicted to result in the amino acid substitution p.Ile41Val. This variant has been reported in an healthy control from a cancer study (Burnichon et al. 2011. PubMed ID: 20923864, referred to as c.121A>G; p.Ile41Val). This variant is reported in 0.018% of alleles in individuals of South Asian descent in gnomAD and has conflicting interpretations in ClinVar ranging from uncertain to likely benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/480774). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 20923864) -
Acute myeloid leukemia Uncertain:1
- -
Hereditary pheochromocytoma-paraganglioma Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 41 of the TMEM127 protein (p.Ile41Val). This variant is present in population databases (rs760633411, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TMEM127-related conditions. ClinVar contains an entry for this variant (Variation ID: 480774). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at